Cite
MLA Citation
T.A. Yap et al.. “NCI10329: Phase Ib Sequential Trial of Agents against DNA Repair (STAR) Study to investigate the sequential combination of the Poly (ADP-Ribose) Polymerase inhibitor (PARPi) olaparib (ola) and WEE1 inhibitor (WEE1i) adavosertib (ada) in patients (pts) with DNA Damage Response (DDR)-aberrant advanced tumors, enriched for BRCA1/2 mutated and CCNE1 amplified cancers.” European journal of cancer, vol. 174, n.d., pp. S7–. http://access.bl.uk/ark:/81055/vdc_100168600564.0x000040